Ascidian Completes Dose Escalation Portion of Phase 1/2 STELLAR Trial of ACDN-01 for Stargardt Disease and Announces Expanded Clinical Study Plans

B STELLAR to begin enrolling pediatric subjects STARPATH prescreening study open for adults and children with Stargardt disease to streamline entry into future ACDN-01 clinical…
posteditor
posteditor
Articles: 21727

Other News